Target intelligence / Profile preview

Soluble bacterial toxins (None)

Target
None
Molecular classification
Enzyme, Other
01

Overview

Soluble bacterial toxins, primarily known as exotoxins, are potent proteins secreted by pathogenic bacteria that cause systemic or localized damage to host tissues (StatPearls, 2023). These toxins are highly diverse and function through various mechanisms, including enzymatic modification of host proteins (e.g., ADP-ribosylation), pore formation in cell membranes, or acting as superantigens to trigger massive immune responses (Nature Reviews Microbiology, 2018). They are critical virulence factors in diseases such as anthrax, botulism, and Clostridioides difficile infection (PubMed, 2021). Therapeutic strategies involve neutralizing these toxins using monoclonal antibodies like bezlotoxumab or raxibacumab to prevent their binding to host receptors or to inhibit their enzymatic activity (FDA, 2016; FDA, 2012). Because toxins often cause the primary symptoms of an infection, targeting them is a vital adjunct to antibiotic therapy, especially when the bacteria themselves are difficult to eradicate or when toxin release is triggered by bacterial lysis (Journal of Clinical Investigation, 2017).

Other names
Bacterial exotoxinsSecreted bacterial toxinsBacterial protein toxins
02

Mechanism of action

Neutralization of toxin activity by preventing receptor binding, inhibiting membrane translocation, or blocking enzymatic function.

03

Biological functions

Cell deathImmune responseOther
04

Disease associations

InfectionInflammation
05

Safety considerations

Hypersensitivity reactionsSerum sicknessImmunogenicityNarrow therapeutic window
06

Interacting drugs

Bezlotoxumab

5 more in the full profile.

07

Biomarkers

Serum toxin levelsStool toxin assaysPCR for toxin-encoding genes

Beyond the preview

Go deeper on Soluble bacterial toxins (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Soluble bacterial toxins (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call